IUPAC name
Other names
1617-53-4 YesY
3D model (Jmol) Interactive image
ChemSpider 4444919 YesY
PubChem 5281600
Molar mass 538.46 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYN ?)
Infobox references

Amentoflavone is a biflavonoid (bis-apigenin coupled at 8 and 3' positions, or 3,8-biapigenin) constituent of a number of plants including Ginkgo biloba, Chamaecyparis obtusa (hinoki), Hypericum perforatum (St. John’s Wort)[1] and Xerophyta plicata.[2]

Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body.[3] It is also an inhibitor of human cathepsin B.[1]

Amentoflavone has a variety of in vitro activities including antimalarial activity,[4] anticancer activity (which may, at least in part, be mediated by its inhibition of fatty acid synthase),[5][6][7] and antagonist activity at the κ-opioid receptor (Ke = 490 nM)[8] as well as activity at the allosteric benzodiazepine site of the GABAA receptor as a negative allosteric modulator.[9]

See also


  1. 1 2 Pan X, Tan N, Zeng G, Zhang Y, Jia R (October 2005). "Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B". Bioorg. Med. Chem. 13 (20): 5819–25. doi:10.1016/j.bmc.2005.05.071. PMID 16084098.
  2. Williams, Christine A.; Harborne, Jeffrey B.; Tomas-Barberan A., Francisco (1987). "Biflavonoids in the primitive monocots Isophysis tasmanica and Xerophyta plicata". Phytochemistry. 26 (9): 2553. doi:10.1016/S0031-9422(00)83875-3.
  3. Kimura, Y; Ito, H; Ohnishi, R; Hatano, T (January 2010). "Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity". Food Chemistry Toxicology. 48 (1): 429–35. doi:10.1016/j.fct.2009.10.041. PMID 19883715.
  4. "Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP)".
  5. Lee, JS; Lee, MS; Oh, WK; Sul, JY (August 2009). "Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells" (PDF). Biological & Pharmaceutical Bulletin. 32 (8): 1427–1432. doi:10.1248/bpb.32.1427. PMID 19652385.
  6. Wilsky, S; Sobotta, K; Wiesener, N; Pilas, J; Althof, N; Munder, T; Wutzler, P; Henke, A (February 2012). "Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication". Archives of Virology. 157 (2): 259–269. doi:10.1007/s00705-011-1164-z. PMID 22075919.
  7. Lee, JS; Sul, JY; Park, JB; Lee, MS; Cha, EY; Song, IS; Kim, JR; Chang, ES (May 2013). "Fatty Acid Synthase Inhibition by Amentoflavone Suppresses HER2/neu(erbB2) Oncogene in SKBR3 Human Breast Cancer Cells". Phytotherapy Research. 27 (5): 713–720. doi:10.1002/ptr.4778. PMID 22767439.
  8. Katavic PL, Lamb K, Navarro H, Prisinzano TE (August 2007). "Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships". J Nat Prod. 70 (8): 1278–82. doi:10.1021/np070194x. PMC 2265593Freely accessible. PMID 17685652.
  9. Hanrahan, JR; Chebib, M; Davucheron, NL; Hall, BJ; Johnston, GA (2003). "Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors". Bioorganic & Medicinal Chemistry Letters. 13 (14): 2281–4. doi:10.1016/s0960-894x(03)00434-7. PMID 12824018.

This article is issued from Wikipedia - version of the 6/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.